Thomas WALTER

Publications

Article dans une revue (167)

European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents Michaela Kuhlen,Calogero Virgone,Antje Redlich,Michael Abele,Ricardo Lopez-Almarazet al. Pediatric Blood and Cancer, 2026, pp.e70194. ⟨10.1002/1545-5017.70194⟩ Article dans une revue hal-05555905v1
LUNG CARCINOIDS (Lung Neuroendocrine Tumors) Anna Koumarianou,Jules Derks,Marina Tsoli,Marco Volante,Lynnette Fernandez-Cuestaet al. Endocrine reviews, 2026, ⟨10.1210/endrev/bnag001⟩ Article dans une revue hal-05457268v1
Clinical and Pathological Features of EC-cell Familial Small Intestine Neuroendocrine Tumors: A Nationwide Cohort From the French GTE-RENATEN Network Thomas Hunaut,Laura Gerard,Agathe Hercent,Olivia Hentic,Bruno Buecheret al. Endocrine Pathology, 2026, 37, pp.15. ⟨10.1007/s12022-026-09913-3⟩ Article dans une revue hal-05562456v1
European Society of Neuroendocrine Tumors ( ENETS ) 2025 guidance paper for lung and thymic carcinoids Eric Baudin,Alice Durand,Wieneke Buikhuisen,Jaume Capdevila,Martyn Caplinet al. Journal of Neuroendocrinology, 2026, 38 (4), pp.e70174. ⟨10.1111/jne.70174⟩ Article dans une revue hal-05583642v1
Large Language Models for Patient Education: Insights from Cross-Lingual Expert Evaluation in Radioligand Therapy for Neuroendocrine Tumors Vincent Habouzit,Alice Durand,Laure Al Mansour,Boumediene Lachachi,Sarah Chaibet al. Journal of Cancer Education, 2026, ⟨10.1007/s13187-026-02886-1⟩ Article dans une revue hal-05606558v1
Transcatheter valve replacement in carcinoid heart disease: A potential change of paradigm Marie-Anne Barbier,Laura Gerard,Daniel Grinberg,Laurent François,Thomas Walteret al. Interdisciplinary Cardiovascular and Thoracic Surgery, 2026, ⟨10.1093/icvts/ivag001⟩ Article dans une revue hal-05451474v1
Neuroendocrine Tumors and Pregnancy: The French PregNET Study Laura Gerard,Charlotte Juin,Marine Perrier,Guillaume Cadiot,Christine Do Caoet al. European Journal of Endocrinology, 2026, ⟨10.1093/ejendo/lvag061⟩ Article dans une revue hal-05591715v1
Long-read sequencing identifies aberrant fragmentation patterns linked to elevated cell-free DNA levels in cancer Benjamin Berman,Sarah Erdman,Christina Wheeler,Justin Cayford,Jean-Valery Turatsinzeet al. Genome Biology, 2026, ⟨10.1186/s13059-026-04060-8⟩ Article dans une revue hal-05588436v1
Nivolumab ± Ipilimumab in Patients With Pretreated Advanced Neuroendocrine Carcinoma: The GCO-001 NIPINEC Randomized Phase II Trial Thomas Pierre Walter,Julien Mazieres,Josiane Otto,Hervé Lena,Côme Lepageet al. Journal of Clinical Oncology, 2026, pp.JCO2501657. ⟨10.1200/JCO-25-01657⟩ Article dans une revue hal-05536623v1
Surgical Management of Zollinger‐Ellison Syndrome in Multiple Endocrine Neoplasia Type 1 an AFCE and GTE Cohort Study. (Association Francophone de Chirurgie Endocrinienne and Groupe d'étude des Tumeurs Endocrines) Sébastien Gaujoux,François Pattou,Guillaume Cadiot,Mustapha Adham,Philippe Bachellieret al. World Journal of Surgery, In press, Online ahead of print. ⟨10.1002/wjs.70303⟩ Article dans une revue hal-05562450v1
A Randomized clinical trial evaluating the impact on survival and quality of life of 177Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217) Jaume Capdevila,Virginia Pubul,Urbano Anido,Thomas Walter,Javier Molina-Cerrilloet al. BMC Cancer, 2025, 25 (1), pp.613. ⟨10.1186/s12885-025-13941-3⟩ Article dans une revue hal-05022367v1
PFMG2025–integrating genomic medicine into the national healthcare system in France Caroline Abadie,Aldja Abderrahmane,Ouarda Abdous,Carine Abel,Oanez Ackermannet al. The Lancet Regional Health - Europe, 2025, 50, pp.101183. ⟨10.1016/j.lanepe.2024.101183⟩ Article dans une revue hal-04988732v1
The European Prospective Investigation into Cancer and Nutrition Cohort (EPIC): a gateway to rare cancer epidemiological research L. Fernandez-Cuesta,C. Voegele,B. Hemon,K. Alcala,D. Auneet al. ESMO Rare Cancers, 2025, 2, pp.100014. ⟨10.1016/j.esmorc.2025.100014⟩ Article dans une revue hal-05165346v1
PRRT plus holmium‐166‐ SIRT ( HEPAR PLuS ) versus PRRT ‐only in patients with metastatic neuroendocrine tumors: A propensity‐score matched analysis W. Veldhuis,Thomas Walter,D. de Vries-Huizing,J. Theysohn,S. Bartonet al. Journal of Neuroendocrinology, 2025, pp.e70034. ⟨10.1111/jne.70034⟩ Article dans une revue hal-05056032v1
Surgical planning of small intestine neuroendocrine tumors: the concept of mesenteric tumor deposits Romain L’huillier,Gilles Poncet,Arnaud Pasquer,Thomas Walter,Catherine Lombard-Bohaset al. Endocrine Oncology, 2025, 5 (1), ⟨10.1530/EO-24-0056⟩ Article dans une revue hal-04987278v1
Cold snaring vs. standard forceps biopsy in sampling colorectal cancer: a comparative case report Simona Agazzi,Eukene Rojo,Elena de Cristofaro,Jérôme Rivory,Thomas Walteret al. Endoscopy, 2025, 57 (S 01), pp.E190-E191. ⟨10.1055/a-2535-1929⟩ Article dans une revue hal-04987279v1
Proof of concept and design of an externally controlled trial for patients with gastro-enteropancreatic neuroendocrine carcinomas based on the randomized phase II BEVANEC trial S. Ganame,Thomas Walter,Alain Durand,A. Lièvre,D. Tougeronet al. European Journal of Cancer, 2025, pp.115450. ⟨10.1016/j.ejca.2025.115450⟩ Article dans une revue hal-05062946v1
Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study Kohei Shitara,Sylvie Lorenzen,Jin Li,Yuxian Bai,Manuel González Fernándezet al. Journal of Clinical Oncology, 2025, ⟨10.1200/JCO-25-00748⟩ Article dans une revue hal-05106538v1
Basic science and translational implications of current knowledge on neuroendocrine tumors Lynnette Fernandez-Cuesta,Nicolas Alcala,Emilie Mathian,Jules Derks,Chrissie Thirlwellet al. The Journal of clinical investigation, 2025, 135 (5), pp.960-971. ⟨10.1172/JCI186702⟩ Article dans une revue hal-04987277v1
Comprehensive molecular portrait reveals genetic diversity and distinct molecular subtypes of small intestinal neuroendocrine tumors Céline Patte,Roxane Pommier,Anthony Ferrari,Felicia Fei-Lei Chung,Maria Ouzounovaet al. Nature Communications, 2025, 16 (1), pp.2197. ⟨10.1038/s41467-025-57305-8⟩ Article dans une revue hal-04987274v1
Interference With VIP to Distinguish Between Real and False VIPoma: National Study From the French Endocrine Tumors Group Benjamin Chevalier,Delphine Bonnet,Come Lepage,Marine Perrier,Françoise Borson-Chazotet al. Journal of the Endocrine Society, 2024, 8 (7), pp.188-194. ⟨10.1210/jendso/bvae102⟩ Article dans une revue hal-04934196v1
Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O 6 -Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET) Thomas Walter,Thierry Lecomte,Julien Hadoux,Patricia Niccoli,Léa Saban-Rocheet al. Journal of Clinical Oncology, 2024, ⟨10.1200/JCO.23.02724⟩ Article dans une revue hal-04886197v1
Histopronostic factors in superficial colorectal adenocarcinomas treated by endoscopy: reproducibility and impact of immunohistochemistry and digital pathology Guillaume Pontarollo,Maxime Bonjour,Thomas Walter,Mathieu Pioche,Pierre-Marie Lavrutet al. Virchows Archiv, 2024, ⟨10.1007/s00428-023-03722-3⟩ Article dans une revue hal-04490334v1
Survival of patients managed in France for duodenal neuroendocrine tumors (D-NET): a 20-year multicenter cohort study from the GTE group: a cohort study Margaux Mekkan-Bouv Hez,Lea Derbey,Louis de Mestier,Lorenzo D,Thomas Walteret al. International Journal of Surgery, 2024, ⟨10.1097/js9.0000000000001382⟩ Article dans une revue hal-04575949v1
Outcome on Mesenteric Mass Response of Small-Intestinal Neuroendocrine Tumors Treated by 177 Lu-DOTATATE Peptide Receptor Radionuclide Therapy: The MesenLuth Study, a National Study from the French Group of Endocrine Tumors and Endocan-RENATEN Network Laure Al Mansour,Louis de Mestier,Magalie Haissaguerre,Pauline Afchain,Julien Hadouxet al. Journal of Nuclear Medicine, 2024, 65 (2), pp.258-263. ⟨10.2967/jnumed.123.266063⟩ Article dans une revue hal-04465202v1
Duodenal neuroendocrine tumor successfully removed by endoscopic submucosal dissection with adaptative traction device Elena de Cristofaro,Jérôme Rivory,Thomas Walter,Jérémie Jacques,Timothée Wallenhorstet al. Endoscopy, 2024, 56 (S 01), pp.E317-E318. ⟨10.1055/a-2291-9448⟩ Article dans une revue hal-04647923v1
Systematic Resection of the Visible Scar After Incomplete Endoscopic Resection of Rectal Neuroendocrine Tumors Loïc Cheminel,Alexandru Lupu,Timothée Wallenhorst,Vincent Lepilliez,Sarah Leblancet al. The American Journal of Gastroenterology, 2024, 119 (2), pp.378-381. ⟨10.14309/ajg.0000000000002516⟩ Article dans une revue hal-04435460v1
Assessment of the current and emerging criteria for the histopathological classification of lung neuroendocrine tumours in the lungNENomics project É. Mathian,Y. Drouet,A. Sexton-Oates,M.G. Papotti,G. Pelosiet al. ESMO Open, 2024, 9 (6), pp.103591. ⟨10.1016/j.esmoop.2024.103591⟩ Article dans une revue hal-04655442v1
Peptide Receptor Radionuclide Therapy or Everolimus in Metastatic Neuroendocrine Tumors: The SeqEveRIV Study, a National Study from the French Group of Endocrine Tumors and Endocan–RENATEN Network Aurelien Fosse,Julien Hadoux,Paul Girot,Amandine Beron,Pauline Afchainet al. Journal of Nuclear Medicine, 2024, pp.jnumed.123.267363. ⟨10.2967/jnumed.123.267363⟩ Article dans une revue hal-04675518v1
Serum and urinary 5-hydroxyindolacetic acid, serotonin, chromogranin A, and NT-proBNP for the detection of carcinoid heart disease Antoine Lecoeur,Rita-Maria Sfeir,Laura Gerard,Myriam Souifi,Johanna Damouret al. European Journal of Endocrinology, 2024, 191 (6), pp.570-578. ⟨10.1093/ejendo/lvae150⟩ Article dans une revue hal-04886186v1
French guidelines from the GTE, AFCE and ENDOCAN-RENATEN (Groupe d’étude des Tumeurs Endocrines/Association Francophone de Chirurgie Endocrinienne/Reseau national de prise en charge des tumeurs endocrines) for the screening, diagnosis and management of Multiple Endocrine Neoplasia Type 1 Pierre Goudet,Guillaume Cadiot,Anne Barlier,Eric Baudin,Françoise Borson-Chazotet al. Annales d'Endocrinologie = Annals of Endocrinology, 2024, 85 (1), pp.2-19. ⟨10.1016/j.ando.2023.09.003⟩ Article dans une revue hal-04490329v1
Neuropilin 2 and soluble neuropilin 2 in neuroendocrine neoplasms Laura Gerard,Céline Patte,Laurence Chardon,Valérie Hervieu,Léa Payenet al. Endocrine-Related Cancer, 2024, 31 (6), ⟨10.1530/ERC-24-0052⟩ Article dans une revue hal-04638761v1
Beyond MEN1, When to Think About MEN4? Retrospective Study on 5600 Patients in the French Population and Literature Review Benjamin Chevalier,Lucie Coppin,Pauline Romanet,Thomas Cuny,Jean-Christophe Maïzaet al. Journal of Clinical Endocrinology and Metabolism, 2024, ⟨10.1210/clinem/dgae055⟩ Article dans une revue hal-04522637v1
ASO Visual Abstract: The Need of Centralization for Small Intestinal Neuroendocrine Tumor Surgery—A Cohort Study from the GTE-Endocan-RENATEN Network, the CentralChirSINET Study Maroin Kalifi,Sophie Deguelte,Matthieu Faron,Pauline Afchain,Louis de Mestieret al. Annals of Surgical Oncology, 2023, 31 (2), pp.1144-1145. ⟨10.1245/s10434-023-14382-7⟩ Article dans une revue hal-04490348v1
Characteristics and treatment options of glucagonomas: a national study from the French Group of Endocrine Tumors and ENDOCAN-RENATEN network Marine Perrier,Mathias Brugel,Laura Gerard,Bernard Goichot,Astrid Lièvreet al. European Journal of Endocrinology, 2023, European Journal of Endocrinology, 189 (6), pp.575-583. ⟨10.1093/ejendo/lvad157⟩ Article dans une revue hal-04338301v1
Surgery of primary lung carcinoid tumors at metastatic stage: A national study from the French Group of Endocrine Tumors ( GTE ) and ENDOCAN‐RENATEN network Lucie Duponchelle,Eric Baudin,Fabien Subtil,Christine Do Cao,Eric Dansinet al. Journal of Neuroendocrinology, 2023, 35 (10), ⟨10.1111/jne.13331⟩ Article dans une revue hal-04517673v1
A practical proposal on treatment sequencing of metastatic well-differentiated neuroendocrine tumours Thomas Walter,Marine Perrier,Jean-Yves Scoazec Therapeutic Advances in Medical Oncology, 2023, 15, pp.175883592311710. ⟨10.1177/17588359231171041⟩ Article dans une revue (article de synthèse) hal-04489754v1
Antineoplastic chemotherapy and immunosuppression in liver transplant recipients: Squaring the circle? Antoine Coupier,Yves Gallien,Olivier Boillot,Thomas Walter,Olivier Guillaudet al. Clinical Transplantation, 2023, 37 (1), pp.e14841. ⟨10.1111/ctr.14841⟩ Article dans une revue hal-04183824v1
EUS-guided radiofrequency ablation of pancreatic neoplasm is far from being the new criterion standard Milenea Muzzolini,Thomas Walter,Sébastien Gaujoux Gastrointestinal Endoscopy, 2023, 98 (6), pp.1039-1040. ⟨10.1016/j.gie.2023.07.023⟩ Article dans une revue hal-04490396v1
Recurrence after surgical resection of nonmetastatic sporadic gastrinoma: Which prognostic factors and surgical procedure? Léa Robin,Alain Sauvanet,Thomas Walter,Haythem Najah,Massimo Falconiet al. Surgery, 2023, 173 (5), pp.1144-1152. ⟨10.1016/j.surg.2022.12.030⟩ Article dans une revue hal-04489743v1
OPERA: perception of information in patients with gastroenteropancreatic neuroendocrine tumors on lanreotide autogel Vincent Hautefeuille,Thomas Walter,Christine Do Cao,Romain Coriat,Sophie Dominguezet al. European Journal of Endocrinology, 2023, 189 (2), pp.281-289. ⟨10.1093/ejendo/lvad094⟩ Article dans une revue hal-04489831v1
COVID-19 in patients with neuroendocrine neoplasms: 2-year results of the INTENSIVE study Nicola Fazio,Lorenzo Gervaso,Thorvardur Halfdanarson,Mohamad Sonbol,Rachel Eiringet al. Endocrine-Related Cancer, 2023, 30 (6), ⟨10.1530/erc-22-0395⟩ Article dans une revue hal-04489844v1
From netrin‐1‐targeted &lt;scp&gt;SPECT&lt;/scp&gt; / &lt;scp&gt;CT&lt;/scp&gt; to internal radiotherapy for management of advanced solid tumors David Kryza,Jennifer Wischhusen,Mathieu Richaud,Maëva Hervieu,Jacqueline Sidi Boumedineet al. EMBO Molecular Medicine, 2023, 15, ⟨10.15252/emmm.202216732⟩ Article dans une revue hal-04107206v1
The Need for Centralization for Small Intestinal Neuroendocrine Tumor Surgery: A Cohort Study from the GTE-Endocan-RENATEN Network, the CentralChirSINET Study Maroin Kalifi,Sophie Deguelte,Matthieu Faron,Pauline Afchain,Louis de Mestieret al. Annals of Surgical Oncology, 2023, 30 (13), pp.8528-8541. ⟨10.1245/s10434-023-14276-8⟩ Article dans une revue hal-04490380v1
High Tumor Uptake on 18 F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d’étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network Ophélie de Rycke,Marine Perrier,Éric Ouvrard,Clément Mennetrey,Choaib Lachachiet al. Journal of Nuclear Medicine, 2023, 64 (11), pp.1699-1705. ⟨10.2967/jnumed.123.265584⟩ Article dans une revue hal-04490390v1
European Neuroendocrine Tumor Society ( ENETS ) 2023 guidance paper for appendiceal neuroendocrine tumours ( aNET ) Gregory Kaltsas,Thomas Walter,Ulrich Knigge,Christos Toumpanakis,Ana Santoset al. Journal of Neuroendocrinology, 2023, 35 (10), ⟨10.1111/jne.13332⟩ Article dans une revue hal-04489826v1
Adjuvant chemotherapy benefit according to T and N stage in small bowel adenocarcinoma: a large retrospective multicenter study Aziz Zaanan,Julie Henriques,Anthony Turpin,Sylvain Manfredi,Romain Coriatet al. JNCI Cancer Spectrum, 2023, 7 (5), pkad064. ⟨10.1093/jncics/pkad064⟩ Article dans une revue hal-04282951v1
Bevacizumab plus FOLFIRI after failure of platinum–etoposide first-line chemotherapy in patients with advanced neuroendocrine carcinoma (PRODIGE 41-BEVANEC): a randomised, multicentre, non-comparative, open-label, phase 2 trial Thomas Walter,Astrid Lievre,Romain Coriat,David Malka,Farid Elhajbiet al. Lancet Oncology, 2023, 24 (3), pp.297-306. ⟨10.1016/s1470-2045(23)00001-3⟩ Article dans une revue hal-04489738v1
Carcinoid heart disease in patients with midgut neuroendocrine tumours Clémence Delhomme,Thomas Walter,Dimitri Arangalage,Gaspard Suc,Olivia Henticet al. Journal of Neuroendocrinology, 2023, 35 (4), ⟨10.1111/jne.13262⟩ Article dans une revue hal-04489852v1
Necrosis as a strong independent prognostic factor required in the implementation of pathological reporting for pancreatic adenocarcinoma resection specimens Tanguy Fenouil,Pierre Marie Lavrut,Maud Rabeyrin,Mustapha Adham,Kayvan Mohkamet al. Pathology - Research and Practice, 2023, 244, pp.154406. ⟨10.1016/j.prp.2023.154406⟩ Article dans une revue hal-04168612v1
Health care resource use and costs among patients with carcinoid syndrome in France: Analysis of the National Health Insurance Database Marine Perrier,Charbel Mouawad,Delphine Gueguen,Benoit Thomé,Maryse Lapeyre-Mestreet al. Clinics and Research in Hepatology and Gastroenterology, 2023, 47 (7), pp.102177. ⟨10.1016/j.clinre.2023.102177⟩ Article dans une revue hal-04489768v1
Management of neuroendocrine neoplasms: conformity with guidelines in and outside a center of excellence Carole Morin,Keo-Morakort Benedetto,Agathe Deville,Laurent Milot,Aurélie Theillaumaset al. Endocrine Connections, 2022, 11 (6), ⟨10.1530/EC-22-0097⟩ Article dans une revue hal-04490245v1
&lt;sup&gt;18&lt;/sup&gt;F-DOPA PET/CT at the Forefront of Initial or Presurgical Evaluation of Small-Intestine Neuroendocrine Tumors Eric Ouvrard,Louis de Mestier,Caroline Boursier,Boumediene Lachachi,Nicolas Sahakianet al. Journal of Nuclear Medicine, 2022, 63 (12), pp.1865-1870. ⟨10.2967/jnumed.122.263984⟩ Article dans une revue hal-03954228v1
Characterising aggressive pulmonary carcinoids through integrative omics analysis within the lungNENomics Project A. Sexton-Oates,A. Di Genova,L. Mangiante,C. Voegele,Séverine Tabone-Eglingeret al. Journal of Thoracic Oncology, 2022, 17 (9), pp.S45-S46 Article dans une revue cea-04352533v1
Healthcare cost by primary tumour, functioning status and treatment among patients with metastatic neuroendocrine tumours: The LyREMeNET study Marine Perrier,Stéphanie Polazzi,Annie Lemelin,Violaine Fernandez,Stéphanie Labonneet al. Journal of Neuroendocrinology, 2022, 34 (4), ⟨10.1111/jne.13092⟩ Article dans une revue hal-04151010v1
Response to systemic treatments in advanced fibrolamellar carcinoma: A French multicenter retrospective cohort of the AGEO. Xixi Ye-Tran,Mohamed Bouattour,Audrey Perret,Anthony Turpin,Thomas Walteret al. Journal of Clinical Oncology, 2022, 40 (16_suppl), pp.e16194-e16194. ⟨10.1200/JCO.2022.40.16_suppl.e16194⟩ Article dans une revue hal-04489869v1
Value of Somatostatin Receptor PET/CT in Patients With MEN1 at Various Stages of Their Disease Clément Mennetrey,Maëlle Le Bras,Aurélie Bando-Delaunay,Laure Al-Mansour,Magalie Haissaguerreet al. Journal of Clinical Endocrinology and Metabolism, 2022, 107 (5), pp.e2056-e2064. ⟨10.1210/clinem/dgab891⟩ Article dans une revue hal-03662789v1
An International Registry of Peritoneal Carcinomatosis from Appendiceal Goblet Cell Carcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Frederic Mercier,Guillaume Passot,Pierre‐emmanuel Bonnot,Peter Cashin,Wim Ceelenet al. World Journal of Surgery, 2022, 46 (6), pp.1336-1343. ⟨10.1007/s00268-022-06498-w⟩ Article dans une revue hal-04490255v1
Diagnostic endoscopic submucosal dissection for colorectal lesions with suspected deep invasion Adrien Patenotte,Clara Yzet,Timothée Wallenhorst,Fabien Subtil,Sarah Leblancet al. Endoscopy, 2022, 55 (02), pp.192-197. ⟨10.1055/a-1866-8080⟩ Article dans une revue hal-04500038v1
Lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumours: An international double-blind, placebo-controlled randomised phase II trial – Prodige 31 REMINET: An FFCD study Côme Lepage,J-M. Phelip,Astrid Lièvre,Karine Le Malicot,L Dahanet al. European Journal of Cancer, 2022, 175, pp.31-40. ⟨10.1016/j.ejca.2022.07.033⟩ Article dans une revue hal-03810530v1
Second-Line Treatment and Prognostic Factors in Neuroendocrine Carcinoma. Julien Hadoux,Thomas Walter,Christina Kanaan,Ségolène Hescot,Vincent Hautefeuilleet al. Endocrine-Related Cancer, 2022, 29 (10), p.569-580. ⟨10.1530/ERC-22-0102⟩ Article dans une revue hal-03746086v1
887O First multicentric randomized phase II trial investigating the antitumor efficacy of peptide receptor radionucleide therapy with 177Lutetium-Octreotate (OCLU) in unresectable progressive neuroendocrine pancreatic tumor: Results of the OCLURANDOM trial E. Baudin,Thomas Walter,A. Beron,D. Smith,J. Hadouxet al. Annals of Oncology, 2022, 33, pp.S954. ⟨10.1016/j.annonc.2022.07.1013⟩ Article dans une revue hal-04490313v1
Efficacy of EUS-guided hepaticogastrostomy in prolonging survival of patients with perihilar cholangiocarcinoma Armelle Schoch,Andrea Lisotti,Thomas Walter,Fabien Fumex,Sarah Leblancet al. Endoscopic Ultrasound, 2022, 11 (6), pp.487. ⟨10.4103/eus-d-22-00014⟩ Article dans une revue hal-04490222v1
Desmoid tumors located in the abdomen or associated with adenomatous polyposis: French intergroup clinical practice guidelines for diagnosis, treatment, and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR) Nicolas Benech,Sylvie Bonvalot,Armelle Dufresne,Afshin Gangi,Cécile Le Péchouxet al. Digestive and Liver Disease, 2022, 54 (6), pp.737-746. ⟨10.1016/j.dld.2022.03.004⟩ Article dans une revue hal-03925724v1
Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for small bowel neuroendocrine tumors with peritoneal metastasis Roy Hajjar,Frederic Mercier,Guillaume Passot,Arnaud Pasquer,Maximiliano Gelliet al. EJSO - European Journal of Surgical Oncology, 2022, 48 (7), pp.1626-1630. ⟨10.1016/j.ejso.2022.03.019⟩ Article dans une revue hal-04490265v1
Prognosis and chemosensitivity of non-colorectal alimentary tract cancers with microsatellite instability Claire Boyer,David Sefrioui,Romain Cohen,Romain Chautard,Marine Perrieret al. Digestive and Liver Disease, 2022, ⟨10.1016/j.dld.2022.03.011⟩ Article dans une revue hal-03731980v1
Transcatheter Pulmonary Valve Implantation in Carcinoid Heart Disease M. Flagiello,M. Pozzi,L. Francois,A. Al Harthy,J. Forestieret al. Cardiovascular Revascularization Medicine, 2022, 40s, pp.130-134. ⟨10.1016/j.carrev.2021.12.027⟩ Article dans une revue inserm-03831063v1
Oxaliplatin and 5-Fluorouracil in Advanced Well-Differentiated Digestive Neuroendocrine Tumors: A Multicenter National Retrospective Study from the French Group of Endocrine Tumors Paul Girot,Eric Baudin,Hélène Senellart,Nadia Bouarioua,Olivia Henticet al. Neuroendocrinology, 2022, 112 (6), pp.537-546. ⟨10.1159/000518650⟩ Article dans une revue hal-04490284v1
Life expectancy and likelihood of surgery in multiple endocrine neoplasia type 1: AFCE and GTE cohort study Sébastien Gaujoux,Guillaume Martin,Eric Mirallié,Nicolas Regenet,Maëlle Le Braset al. British Journal of Surgery, 2022, 109 (9), pp.872-879. ⟨10.1093/bjs/znac006⟩ Article dans une revue hal-03883938v1
Structural and Socio-Spatial Determinants Influencing Care and Survival of Patients with a Pancreatic Adenocarcinoma: Results of the PANDAURA Cohort Gaël Roth,Yohan Fayet,Sakina Benmameche-Medjahed,Françoise Ducimetière,Amandine Charretonet al. Cancers, 2022, 14 (21), pp.5413. ⟨10.3390/cancers14215413⟩ Article dans une revue hal-04490226v1
Management and Prognosis of Localized Duodenal Neuroendocrine Neoplasms Servane Gay-Chevallier,Louis de Mestier,Julie Perinel,Julien Forestier,Valérie Hervieuet al. Neuroendocrinology, 2021, 111 (8), pp.718-727. ⟨10.1159/000508102⟩ Article dans une revue hal-04179693v1
ctDNA in neuroendocrine carcinoma of gastroenteropancreatic origin or of unknown primary: the CIRCAN-NEC pilot study Laura Gerard,Jessica Garcia,Arnaud Gauthier,Jonathan Lopez,Alice Durandet al. Neuroendocrinology, 2021, ⟨10.1159/000512502⟩ Article dans une revue hal-02999436v1
Endoscopic ultrasound efficacy in staging gastric linitis plastica lesion: a retrospective multicentric French study Stephanie Morgant,Pascal Artru,Ammar Oudjit,Nelson Lourenco,Arnaud Pasqueret al. Annals of translational medicine, 2021, 9 (1), pp.50-50. ⟨10.21037/atm-20-3474⟩ Article dans une revue hal-04492172v1
Alkylating agent rechallenge in metastatic pancreatic neuroendocrine tumors Ophélie de Rycke,Thomas Walter,Marine Perrier,Olivia Hentic,Catherine Lombard-Bohaset al. Endocrine-Related Cancer, 2021, 28 (7), pp.457-466. ⟨10.1530/erc-21-0034⟩ Article dans une revue hal-04492482v1
Plasmatic and Urinary 5-Hydroxyindolacetic Acid Measurements in Patients With Midgut Neuroendocrine Tumors: A GTE Study Louis de Mestier,Frédérique Savagner,Hedia Brixi,Christine Do Cao,Sophie Dominguez-Tinajeroet al. Journal of Clinical Endocrinology and Metabolism, 2021, 106 (4), pp.e1673-e1682. ⟨10.1210/clinem/dgaa924⟩ Article dans une revue hal-03287271v1
Endoscopic resection of Barrett's adenocarcinoma: Intramucosal and low‐risk tumours are not associated with lymph node metastases Nicolas Benech,Jean Marc O'Brien,Maximilien Barret,Jéremie Jacques,Gabriel Rahmiet al. United European Gastroenterology Journal, 2021, 9 (3), pp.362-369. ⟨10.1177/2050640620958903⟩ Article dans une revue hal-04470221v1
cfDNA in pancreatic neuroendocrine carcinoma management with Cushing’s syndrome Laura Gerard,David Barthelemy,Arnaud Gauthier,Valerie Hervieu,Jonathan Lopezet al. Endocrine Oncology, 2021, 1 (1), pp.K1-K6. ⟨10.1530/eo-21-0012⟩ Article dans une revue hal-04492472v1
FOLFIRINEC: a randomized phase II trial of mFOLFIRINOX vs platinum-etoposide for metastatic neuroendocrine carcinoma of gastroenteropancreatic or unknown origin Julien Hadoux,Pauline Afchain,Thomas Walter,David Tougeron,Vincent Hautefeuilleet al. Digestive and Liver Disease, 2021, 53 (7), pp.824-829. ⟨10.1016/j.dld.2021.04.016⟩ Article dans une revue hal-03333521v1
Phase II study evaluating the association of gemcitabine, trastuzumab and erlotinib as first‐line treatment in patients with metastatic pancreatic adenocarcinoma ( GATE 1) Eric Assenat,Laurent Mineur,Caroline Mollevi,Evelyne Lopez-Crapez,Catherine Lombard-Bohaset al. International Journal of Cancer, 2021, 148 (3), pp.682-691. ⟨10.1002/ijc.33225⟩ Article dans une revue hal-03670041v1
Issues and limitations of available biomarkers for fluoropyrimidine-based chemotherapy toxicity, a narrative review of the literature K. Hodroj,D. Barthelemy,J.-C. Lega,G. Grenet,M.-C. Gagnieuet al. ESMO Open, 2021, 6 (3), pp.100125. ⟨10.1016/j.esmoop.2021.100125⟩ Article dans une revue hal-04492195v1
Value of a patient-reported-outcome measure of carcinoid syndrome symptoms Juliette Maurel,Rosine Guimbaud,Thierry Lecomte,Astrid Lièvre,Vincent Hautefeuilleet al. European Journal of Endocrinology, 2021, 184 (5), pp.711-722. ⟨10.1530/EJE-20-1138⟩ Article dans une revue hal-04179679v1
Impact of the First Wave of the COVID-19 Pandemic on the Lyon University Hospital Cancer Institute (IC-HCL) Anne-Sophie Belmont,Christophe Sajous,Amandine Bruyas,Sara Calattini,Stéphanie Cartalatet al. Cancers, 2021, 14 (1), pp.29. ⟨10.3390/cancers14010029⟩ Article dans une revue hal-04490309v1
Unifocal versus multiple ileal neuroendocrine tumors location: an embryological origin Maroin Kalifi,Thomas Walter,Laurent Milot,Valérie Hervieu,Ingrid Millotet al. Neuroendocrinology, 2021, ⟨10.1159/000511849⟩ Article dans une revue hal-02999432v1
Targeting netrin‐3 in small cell lung cancer and neuroblastoma Shan Jiang,Mathieu Richaud,Pauline Vieugué,Nicolas Rama,Jean‐guy Delcroset al. EMBO Molecular Medicine, 2021, 13 (4), ⟨10.15252/emmm.202012878⟩ Article dans une revue hal-03410529v1
Management of Patients with Pancreatic Ductal Adenocarcinoma in the Real-Life Setting: Lessons from the French National Hospital Database Christelle de la Fouchardière,Mustapha Adham,Anne-Marie Marion-Audibert,Antoine Duclos,Claude Darchaet al. Cancers, 2021, 13 (14), pp.3515. ⟨10.3390/cancers13143515⟩ Article dans une revue hal-04492495v1
Principles of Surgical Management of Small Intestinal NET Arnaud Pasquer,Thomas Walter,Laurent Milot,Valérie Hervieu,Gilles Poncet Cancers, 2021, 13 (21), pp.5473. ⟨10.3390/cancers13215473⟩ Article dans une revue hal-04492163v1
Is the Morphological Subtype of Extra-Pulmonary Neuroendocrine Carcinoma Clinically Relevant? Melissa Frizziero,Alice Durand,Rodrigo Taboada,Elisa Zaninotto,Claudio Luchiniet al. Cancers, 2021, 13 (16), pp.4152. ⟨10.3390/cancers13164152⟩ Article dans une revue hal-04492480v1
Efficacy of treatments for VIPoma: A GTE multicentric series Mathias Brugel,Thomas Walter,Bernard Goichot,Denis Smith,Côme Lepageet al. Pancreatology, 2021, 21 (8), pp.1531-1539. ⟨10.1016/j.pan.2021.08.001⟩ Article dans une revue hal-04492502v1
Prognostic factors of metastatic neuroendocrine carcinoma under first-line treatment with platinum etoposide with a focus on NEC score and Rb expression: Results from the multicentre RBNEC study of the Groupe d'Etude des Tumeurs Endocrines (GTE) and the ENDOCAN-RENATEN network Julien Hadoux,Christina Kanaan,Alice Durand,Segolene Hescot,Vincent Hautefeuilleet al. European journal of cancer, 2021, 152, pp.100-115. ⟨10.1016/j.ejca.2021.04.030⟩ Article dans une revue hal-03600262v1
Differential diagnosis of diarrhoea in patients with neuroendocrine tumours: A systematic review Mohid Khan,Thomas Walter,Amy Buchanan-Hughes,Emma Worthington,Lucie Keeberet al. World Journal of Gastroenterology, 2020, 26 (30), pp.4537-4556. ⟨10.3748/wjg.v26.i30.4537⟩ Article dans une revue hal-04492712v1
Elderly Patients with Metastatic Neuroendocrine Tumors Are Undertreated and Have Shorter Survival: The LyREMeNET Study Annie Lemelin,Delphine Maucort-Boulch,Elisabeth Castel-Kremer,Julien Forestier,Valérie Hervieuet al. Neuroendocrinology, 2020, 110 (7-8), pp.653-661. ⟨10.1159/000503901⟩ Article dans une revue hal-04151916v1
Diagnostic endoscopic submucosal dissection with targeted tunnel to reach the suspect area first in order to diagnose muscular invasion and differentiate T1b from T2 cancers Camille Meunier,Jérémie Jacques,Jérôme Rivory,Thomas Lambin,Thomas Walteret al. Endoscopy, 2020, 53 (08), pp.870-871. ⟨10.1055/a-1268-7057⟩ Article dans une revue hal-04470335v1
Endoscopic ultrasound-guided gastrostomy to avoid interposed digestive loop is effective when lack of transillumination prevents percutaneous approach Juliette Maurel,Gaspard Bertrand,Florian Beoletto,Thierry Ponchon,Thomas Walteret al. Endoscopy, 2020, 52 (11), pp.E402-E403. ⟨10.1055/a-1149-1224⟩ Article dans une revue hal-04493508v1
Chemotherapy in resected neuroendocrine carcinomas of the digestive Anna Pellat,Thomas Walter,Jeremy Augustin,Vincent Hautefeuille,Olivia Henticet al. Neuroendocrinology, 2020, 110 (5), pp.404-412. ⟨10.1159/000502825⟩ Article dans une revue hal-02996214v1
Cost-effectiveness of Lutetium [ 177 Lu] oxodotreotide versus best supportive care with octreotide in patients with midgut neuroendocrine tumors in France O. Leeuwenkamp,J. Smith-Palmer,R. Ortiz,A. Werner,W. Valentineet al. Journal of Medical Economics, 2020, 23 (12), pp.1534-1541. ⟨10.1080/13696998.2020.1830286⟩ Article dans une revue hal-04492707v1
Metformin and everolimus in neuroendocrine tumours: A synergic effect? Lucia Hue-Fontaine,Annie Lemelin,Julien Forestier,Gerald Raverot,Laurent Milotet al. Clinics and Research in Hepatology and Gastroenterology, 2020, 44, pp.954 - 960. ⟨10.1016/j.clinre.2020.02.011⟩ Article dans une revue hal-03492643v1
Risk of neoplastic change in large gastric hyperplastic polyps and recurrence after endoscopic resection Emmanuel Forté,Bérénice Petit,Thomas Walter,Vincent Lépilliez,Geoffroy Vanbiervlietet al. Endoscopy, 2020, 52 (06), pp.444-453. ⟨10.1055/a-1117-3166⟩ Article dans une revue hal-04179697v1
Endoscopic characterization of rectal neuroendocrine tumors with virtual chromoendoscopy: differences between benign and malignant lesions Florian Veyre,Thomas Lambin,Caroline Fine,Tanguy Fenouil,Florian Rostainet al. Endoscopy, 2020, 53 (06), pp.E215-E216. ⟨10.1055/a-1244-9526⟩ Article dans une revue hal-04491996v1
Post first-line dacarbazine or temozolomide in neuroendocrine carcinoma Thomas Couronne,Paul Girot,Julien Hadoux,Thierry Lecomte,Alice Durandet al. Endocrine Connections, 2020, 9 (6), pp.498-505. ⟨10.1530/ec-20-0192⟩ Article dans une revue hal-04492751v1
Clinical usefulness of FDG-PET for management of well-differentiated digestive neuroendocrine tumors Marine Perrier,Olivia Hentic,Thomas Walter,Christine Do Cao,Guillaume Cadiotet al. Digestive and Liver Disease, 2020, 52 (12), pp.1521-1524. ⟨10.1016/j.dld.2020.09.001⟩ Article dans une revue hal-04492690v1
Systematic review and network meta-analyses of third-line treatments for metastatic colorectal cancer Thomas Walter,Neil Hawkins,Richard Pollock,Fabien Colaone,Suki Shergillet al. Journal of Cancer Research and Clinical Oncology, 2020, 146 (10), pp.2575-2587. ⟨10.1007/s00432-020-03315-6⟩ Article dans une revue hal-04492656v1
Digestive Neuroendocrine Neoplasms (NEN): French Intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, GTE, RENATEN, TENPATH, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR) Louis de Mestier,Come Lepage,Eric Baudin,Romain Coriat,Frédéric Courbonet al. Digestive and Liver Disease, 2020, 52 (5), pp.473-492. ⟨10.1016/j.dld.2020.02.011⟩ Article dans une revue hal-04492748v1
Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine Tumor Louis de Mestier,Thomas Walter,Camille Evrard,Paul de Boissieu,Olivia Henticet al. Neuroendocrinology, 2020, 110 (1-2), pp.83-91. ⟨10.1159/000500862⟩ Article dans une revue hal-04492743v1
Prospective comparison of whole-body MRI with diffusion-weighted and conventional imaging for the follow-up of neuroendocrine tumors Maximilien Minon,Clothilde Soriano,David Morland,Thomas Walter,Côme Lepageet al. Endocrine, 2020, 67, pp.243-251. ⟨10.1007/s12020-019-02095-5⟩ Article dans une revue hal-02478376v1
Extrapulmonary poorly differentiated NECs, including molecular and immune aspects Mairéad Mcnamara,Jean-Yves Scoazec,Thomas Walter Endocrine-Related Cancer, 2020, 27 (7), pp.R219-R238. ⟨10.1530/erc-19-0483⟩ Article dans une revue hal-04493496v1
O6-methylguanine-DNA methyltransferase (MGMT) status in neuroendocrine tumors: a randomized phase II study (MGMT-NET) Annie Lemelin,Marc Barritault,Valérie Hervieu,Léa Payen,Julien Péronet al. Digestive and Liver Disease, 2019, 51, pp.595 - 599. ⟨10.1016/j.dld.2019.02.001⟩ Article dans une revue hal-03486315v1
Current Management and Predictive Factors of Lymph Node Metastasis of Appendix Neuroendocrine Tumors : A National Study from the French Group of Endocrine Tumors (GTE) Bérénice Rault-Petit,Christine Do Cao,Serge Guyétant,Rosine Guimbaud,Vincent Rohmeret al. Annals of Surgery, 2019, 270 (1), pp.165-171. ⟨10.1097/SLA.0000000000002736⟩ Article dans une revue hal-02547901v1
Comparison of Temozolomide-Capecitabine to 5-Fluorouracile-Dacarbazine in 247 Patients with Advanced Digestive Neuroendocrine Tumors Using Propensity Score Analyses Louis de Mestier,Thomas Walter,Hedia Brixi,Camille Evrard,Jean-Louis Legouxet al. Neuroendocrinology, 2019, 108 (4), pp.343-353. ⟨10.1159/000498887⟩ Article dans une revue hal-04493972v1
Evaluation of a strategy using pretherapeutic fiducial marker placement to avoid missing liver metastases V. Kepenekian,A. Muller,P. Valette,P. Rousset,M. Chauvenetet al. BJS Open, 2019, 3 (3), pp.344-353. ⟨10.1002/bjs5.50140⟩ Article dans une revue hal-04493892v1
Retrospective study on mixed neuroendocrine non-neuroendocrine neoplasms from five European centres Melissa Frizziero,Xin Wang,Bipasha Chakrabarty,Alexa Childs,Tu Luonget al. World Journal of Gastroenterology, 2019, 25 (39), pp.5991-6005. ⟨10.3748/wjg.v25.i39.5991⟩ Article dans une revue hal-04493932v1
Endoscopic management of 345 small rectal neuroendocrine tumours: a national study from the French group of endocrine tumours (GTE) Caroline Fine,Guillaume Roquin,Eric Terrebonne,Thierry Lecomte,Romain Coriatet al. United European Gastroenterology Journal, 2019, 7 (8), pp.1102-1112. ⟨10.1177/2050640619861883⟩ Article dans une revue hal-02549178v1
Nonampullary duodenal subepithelial neuroendocrine tumor removed R0 by endoscopic submucosal dissection with double clips and rubber band traction Borathchakra Oung,Thomas Walter,Valérie Hervieu,Jérémie Jacques,Mathieu Pioche VideoGIE, 2019, 4 (12), pp.570-573. ⟨10.1016/j.vgie.2019.08.006⟩ Article dans une revue hal-04493877v1
Characterization, Prognosis, and Treatment of Patients With Metastatic Lung Carcinoid Tumors Patrick Robelin,Julien Hadoux,Julien Forestier,David Planchard,Valérie Hervieuet al. Journal of Thoracic Oncology, 2019, 14, pp.993 - 1002. ⟨10.1016/j.jtho.2019.02.002⟩ Article dans une revue hal-03484938v1
Neuropilin‐2 contributes to tumor progression in preclinical models of small intestinal neuroendocrine tumors Julien Bollard,Céline Patte,Kristina Radkova,Patrick Massoma,Laurence Chardonet al. Journal of Pathology, 2019, 249 (3), pp.343-355. ⟨10.1002/path.5321⟩ Article dans une revue hal-04653929v1
Metabolomics of Small Intestine Neuroendocrine Tumors and Related Hepatic Metastases Alessio Imperiale,Gilles Poncet,Pietro Addeo,Elisa Ruhland,Colette Rocheet al. Metabolites, 2019, 9 (12), pp.300. ⟨10.3390/metabo9120300⟩ Article dans une revue hal-02923574v1
Prognostic and predictive value of nuclear imaging in endocrine oncology Giorgio Treglia,Bernard Goichot,Luca Giovanella,Elif Hindié,Abhishek Jhaet al. Endocrine, 2019, 67 (1), pp.9-19. ⟨10.1007/s12020-019-02131-4⟩ Article dans une revue hal-04492687v1
Endoscopic, transanal, laparoscopic, and transabdominal management of rectal neuroendocrine tumors Louis de Mestier,Diane Lorenzo,Caroline Fine,Jérôme Cros,Olivia Henticet al. Best Practice and Research: Clinical Endocrinology and Metabolism, 2019, 33, pp.101293 -. ⟨10.1016/j.beem.2019.101293⟩ Article dans une revue hal-03489062v1
Everolimus after hepatic arterial embolisation therapy of metastases from gastrointestinal neuroendocrine tumours: The FFCD 1104-EVACEL-GTE phase II study Thomas Walter,Come Lepage,Romain Coriat,Emilie Barbier,Guillaume Cadiotet al. European Journal of Cancer, 2019, 123, pp.92-100. ⟨10.1016/j.ejca.2019.09.021⟩ Article dans une revue hal-04493861v1
Combinatorial Treatment with mTOR Inhibitors and Streptozotocin Leads to Synergistic In Vitro and In Vivo Antitumor Effects in Insulinoma Cells Julien Bollard,Céline Patte,Patrick Massoma,Isabelle Goddard,Nicolas Gadotet al. Molecular Cancer Therapeutics, 2018, 17 (1), pp.60-72. ⟨10.1158/1535-7163.MCT-17-0325⟩ Article dans une revue hal-04494066v1
Computed tomography scan efficacy in staging gastric linitis plastica lesion: a retrospective multicentric French study Stephanie Morgant,Pascal Artru,Ammar Oudjit,Nelson Lourenco,Arnaud Pasqueret al. Cancer Management and Research, 2018, Volume 10, pp.3825-3831. ⟨10.2147/cmar.S163141⟩ Article dans une revue hal-04493982v1
An onco-geriatric approach to select older patients for optimal treatments of pancreatic adenocarcinoma Elisabeth Castel-Kremer,Solene de Talhouet,Anne-Laure Charlois,Emmanuelle Graillot,Xavier Chopin-Lalyet al. Journal of Geriatric Oncology, 2018, 9 (4), pp.373-381. ⟨10.1016/j.jgo.2018.03.007⟩ Article dans une revue hal-04494047v1
Gastric neuroendocrine tumors display deep invasive features, with amorphous pit and irregular vascular pattern, using narrow-band imaging and magnification Adrien Choné,Thomas Walter,Jérôme Rivory,Pierre-Marie Lavrut,Julien Forestieret al. Endoscopy, 2018, 50 (08), pp.E199-E201. ⟨10.1055/a-0606-4792⟩ Article dans une revue hal-04494046v1
Evaluating bevacizumab in combination with FOLFIRI after the failure of platinum-etoposide regimen in patients with advanced poorly differentiated neuroendocrine carcinoma: The PRODIGE 41–BEVANEC randomized phase II study Thomas Walter,David Malka,Olivia Hentic,Catherine Lombard-Bohas,Karine Le Malicotet al. Digestive and Liver Disease, 2018, 50 (2), pp.195-198. ⟨10.1016/j.dld.2017.11.020⟩ Article dans une revue istex hal-01699411v1
Cross-platform comparison for the detection of RAS mutations in cfDNA (ddPCR Biorad detection assay, BEAMing assay, and NGS strategy) Jessica Garcia,Julien Forestier,Eric Dusserre,Anne-Sophie Wozny,Florence Geigueret al. Oncotarget, 2018, 9 (30), pp.21122-21131. ⟨10.18632/oncotarget.24950⟩ Article dans une revue hal-04383088v1
A motivational phone call improves participation to screening colonoscopy for those with a positive FIT in a national screening programme (NCT 03276091) Clémentine Gandilhon,Patricia Soler-Michel,Léa Vecchiato,Claude Chaunier,Isabelle Fayet al. Digestive and Liver Disease, 2018, 50 (12), pp.1309-1314. ⟨10.1016/j.dld.2018.08.007⟩ Article dans une revue hal-04493977v1
Patient-reported tolerance in treatments approved in neuroendocrine tumors: A national survey from the French Group of Endocrine Tumors Arnaud Plante,Eric Baudin,Christine Do Cao,Olivia Hentic,Olivier Dubreuilet al. Clinics and Research in Hepatology and Gastroenterology, 2018, 42 (2), pp.153-159. ⟨10.1016/j.clinre.2017.10.003⟩ Article dans une revue hal-04495704v1
Immunosuppressive regimen and risk for de novo malignancies after liver transplantation for alcoholic liver disease Jérôme Dumortier,Delphine Maucort-Boulch,Domitille Poinsot,Elsa Thimonier,Christine Chambon-Augoyardet al. Clinics and Research in Hepatology and Gastroenterology, 2018, 42 (5), pp.427-435. ⟨10.1016/j.clinre.2018.04.011⟩ Article dans une revue hal-04151948v1
Narrow-band imaging detects synchronous oropharyngeal squamous carcinoma during treatment of an early esophageal squamous cell carcinoma Alexander Katzarov,Alexandru Lupu,Jérémie Jacques,Jérôme Rivory,Florian Rostainet al. Endoscopy, 2018, 50 (09), pp.E264-E266. ⟨10.1055/a-0640-2464⟩ Article dans une revue hal-04495732v1
Intraoperative carcinoid syndrome during small-bowel neuroendocrine tumour surgery Myrtille Fouché,Yves Bouffard,Mary-Charlotte Le Goff,Johanne Prothet,François Malavieilleet al. Endocrine Connections, 2018, 7 (12), pp.1245-1250. ⟨10.1530/ec-18-0324⟩ Article dans une revue hal-04494027v1
Clinical and Biomarker Evaluations of Sunitinib in Patients with Grade 3 Digestive Neuroendocrine Neoplasms Anna Pellat,Chantal Dreyer,Camille Couffignal,Thomas Walter,Catherine Lombard-Bohaset al. Neuroendocrinology, 2018, 107 (1), pp.24-31. ⟨10.1159/000487237⟩ Article dans une revue hal-04495727v1
Correlation between MGMT promoter methylation and response to temozolomide-based therapy in neuroendocrine neoplasms: an observational retrospective multicenter study Davide Campana,Thomas Walter,Sara Pusceddu,Fabio Gelsomino,Emmanuelle Graillotet al. Endocrine, 2017, 60 (3), pp.490-498. ⟨10.1007/s12020-017-1474-3⟩ Article dans une revue hal-04494061v1
Survival and prognostic factors after adjuvant 131iodine-labeled lipiodol for hepatocellular carcinoma: a retrospective analysis of 106 patients over 20 years Jonathan Olesinski,François Mithieux,Olivier Guillaud,Marie-Noëlle Hilleret,Catherine Lombard-Bohaset al. Annals of Nuclear Medicine, 2017, 31 (5), pp.379-389. ⟨10.1007/s12149-017-1165-4⟩ Article dans une revue hal-04173123v1
Management of gastric neuro-endocrine tumours in a large French national cohort (GTE). Sylvain Manfredi,Thomas Walter,Eric Baudin,Philippe Ruszniewski,Thierry Lecomteet al. Endocrine, 2017, 57 (3), pp.504-511. ⟨10.1007/s12020-017-1355-9⟩ Article dans une revue hal-01576810v1
Management of desmoid tumours: A large national database of familial adenomatous patients shows a link to colectomy modalities and low efficacy of medical treatments Thomas Walter,C Zhenzhen Wang,O Guillaud,E Cotte,A Pasqueret al. United European Gastroenterology Journal, 2017, 5 (5), pp.735-741. ⟨10.1177/2050640616678150⟩ Article dans une revue hal-04495896v1
Chemotherapy for Well-Differentiated Pancreatic Neuroendocrine Tumours with a Ki-67 Index ≥10%: Is There a More Effective Antitumour Regimen? A Retrospective Multicentre Study of the French Group of Endocrine Tumours (GTE) Guillaume Roquin,Éric Baudin,Catherine Lombard-Bohas,Guillaume Cadiot,Sophie Dominguezet al. Neuroendocrinology, 2017, 106 (1), pp.38-46. ⟨10.1159/000457955⟩ Article dans une revue hal-02451453v1
Treatment of metastatic pancreatic neuroendocrine tumors: relevance of ENETS 2016 guidelines Margaux Foulfoin,Emmanuelle Graillot,Mustapha Adham,Pascal Rousset,Julien Forestieret al. Endocrine-Related Cancer, 2017, 24 (2), pp.71-81. ⟨10.1530/erc-16-0464⟩ Article dans une revue hal-04494085v1
Maintaining quality of life for patients with neuroendocrine tumours Thomas Walter Lancet Oncology, 2017, 18 (10), pp.1299-1300. ⟨10.1016/s1470-2045(17)30618-6⟩ Article dans une revue hal-04495910v1
Desmoid Tumors and Celecoxib with Sorafenib Nicolas Benech,Thomas Walter,Jean-Christophe Saurin New England Journal of Medicine, 2017, 376 (26), pp.2595-2597. ⟨10.1056/NEJMc1702562⟩ Article dans une revue hal-04495950v1
In Reply Romain Coriat,Benoît Terris,Thomas Walter Oncologist, 2017, 22 (3), pp.359-360. ⟨10.1634/theoncologist.2016-0393⟩ Article dans une revue hal-04495937v1
Design and Validation of the GI-NEC Score to Prognosticate Overall Survival in Patients With High-Grade Gastrointestinal Neuroendocrine Carcinomas Angela Lamarca,Thomas Walter,Marianne Pavel,Ivan Borbath,Patricia Freiset al. JNCI: Journal of the National Cancer Institute, 2017, 109 (5), pp.djw277. ⟨10.1093/jnci/djw277⟩ Article dans une revue hal-04495933v1
Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort T. Walter,T Tougeron,Emmanuel Baudin,K. Le Malicot,T. Lecomteet al. European Journal of Cancer, 2017, 79, pp.158 - 165. ⟨10.1016/j.ejca.2017.04.009⟩ Article dans une revue istex hal-01609152v1
Prognostic factors in neuroendocrine carcinoma: biological markers are more useful than histomorphological markers Patricia Freis,Emmanuelle Graillot,Pascal Rousset,Valérie Hervieu,Laurence Chardonet al. Scientific Reports, 2017, 7 (1), pp.40609. ⟨10.1038/srep40609⟩ Article dans une revue hal-04500093v1
mTOR inhibitors activate PERK signaling and favor viability of gastrointestinal neuroendocrine cell lines Patricia Freis,Julien Bollard,Justine Lebeau,Patrick Massoma,Joëlle Fauvreet al. Oncotarget, 2017, 8 (13), pp.20974-20987. ⟨10.18632/oncotarget.15469⟩ Article dans une revue hal-02379643v1
Evaluating lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumours Come Lepage,Laetitia Dahan,Nadia Bouarioua,Christos Toumpanakis,Jean-Louis Legouxet al. Digestive and Liver Disease, 2017, 49 (5), pp.568 - 571. ⟨10.1016/j.dld.2017.02.004⟩ Article dans une revue istex hal-01599909v1
Type 1 serrated polyposis represents a predominantly female disease with a high prevalence of dysplastic serrated adenomas, without germline mutation in MUTYH, APC , and PTEN genes Marco Petronio,Stephane Pinson,Thomas Walter,Marie‐odile Joly,Valerie Hervieuet al. United European Gastroenterology Journal, 2016, 4 (2), pp.305-313. ⟨10.1177/2050640615594939⟩ Article dans une revue hal-04495988v1
Neuroendocrine tumors producing calcitonin: characteristics, prognosis and potential interest of calcitonin monitoring during follow-up C. Nozieres,L. Chardon,Bernard Goichot,F. Borson-Chazot,V. Hervieuet al. European Journal of Endocrinology, 2016, 174 (3), pp.335-41. ⟨10.1530/EJE-15-0917⟩ Article dans une revue hal-01850353v1
Locally advanced pancreatic duct adenocarcinoma: pancreatectomy with planned arterial resection based on axial arterial encasement J. Perinel,G. Nappo,M. El Bechwaty,Thomas Walter,V. Hervieuet al. Langenbeck's Archives of Surgery, 2016, 401 (8), pp.1131-1142. ⟨10.1007/s00423-016-1488-y⟩ Article dans une revue hal-04496006v1
Evaluation of the combination of oxaliplatin and 5-fluorouracil or gemcitabine in patients with sporadic metastatic pulmonary carcinoid tumors Thomas Walter,D. Planchard,K. Bouledrak,J.Y. Scoazec,P.J. Souquetet al. Lung Cancer, 2016, 96, pp.68-73. ⟨10.1016/j.lungcan.2016.03.018⟩ Article dans une revue istex hal-04495958v1
Radiochemotherapy Versus Surgery in Nonmetastatic Anorectal Neuroendocrine Carcinoma Bertrand Brieau,Céline Lepère,Thomas Walter,Thierry Lecomte,Rosine Guimbaudet al. Medicine, 2015, 94 (42), pp.e1864. ⟨10.1097/MD.0000000000001864⟩ Article dans une revue hal-01301145v1
Evaluation of shearwave elastography for the characterisation of focal liver lesions on ultrasound A. Guibal,C. Boularan,M. Bruce,M. Vallin,F. Pilleulet al. European Radiology, 2013, 23 (4), pp.1138--1149. ⟨10.1007/s00330-012-2692-y⟩ Article dans une revue istex hal-01918694v1
Contrast-enhanced ultrasound after devascularisation of neuroendocrine liver metastases: functional and morphological evaluation A. Guibal,T. Lefort,L. Chardon,N. Benslama,S. Muleet al. European Radiology, 2013, 23 (3), pp.805--815. ⟨10.1007/s00330-012-2646-4⟩ Article dans une revue istex hal-01918695v1
Antitumor Effect of Everolimus in Preclinical Models of High Grade Gastroenteropancreatic Neuroendocrine Carcinomas. Julien Bollard,Christophe Couderc,Martine Blanc,Gilles Poncet,Florian Lepinasseet al. Neuroendocrinology, 2013, epub ahead of print. ⟨10.1159/000347063⟩ Article dans une revue hal-00790198v1
Correlation and agreement between contrast-enhanced ultrasonography and perfusion computed tomography for assessment of liver metastases from endocrine tumors: normalization enhances correlation T. Lefort,F. Pilleul,S. Mule,S. L. Bridal,F. Frouinet al. Ultrasound in Medicine & Biology, 2012, 38 (6), pp.953--961 Article dans une revue hal-01918702v1
Obstructing minute primary endocrine tumor of the main pancreatic duct: diagnostic relevance of endoscopic ultrasonography R. Gincul,T. Walter,B. Napoleon,C. Lombard-Bohas,C. Partenskyet al. Pancreas, 2012, 41 (1), pp.164--165 Article dans une revue hal-01918698v1
Neuroendocrine tumors of Meckel's diverticulum: lessons from a single institution study of eight cases G. Poncet,V. Hervieu,T. Walter,F. Lepinasse,L. Chardonet al. Journal of Gastrointestinal Surgery, 2011, 15 (1), pp.101--109 Article dans une revue hal-01918705v1
F-18-FLT and F-18-FDG positron emission tomography for the imaging of advanced well-differentiated gastro-entero-pancreatic endocrine tumours F. Giammarile,C. Billotey,C. Lombard-Bohas,D. Le Bars,C. Bournaudet al. Nuclear Medicine Communications, 2011, 32, pp.91-97 Article dans une revue hal-02299115v1
Effects of somatostatin and octreotide on the interactions between neoplastic gastroenteropancreatic endocrine cells and endothelial cells: a comparison between in vitro and in vivo properties. Thomas Walter,Juliette Hommell-Fontaine,Géraldine Gouysse,Céline Pourreyron,Mimoun Nejjariet al. Neuroendocrinology, 2011, 94 (3), pp.200-8. ⟨10.1159/000328134⟩ Article dans une revue hal-00710320v1
Well-differentiated pancreatic islet cell carcinoma: Is there reversibility in mTOR inhibitor resistance? Thomas Walter,Jean-Yves Scoazec,Christophe Couderc,Julien Forestier,Colette Rocheet al. Acta Oncologica, 2011, 50 (5), pp.731-2. ⟨10.3109/0284186X.2011.562919⟩ Article dans une revue hal-00710300v1
Primary neuroendocrine tumors of the main pancreatic duct: a rare entity. Thomas Walter,Valérie Hervieu,Mustapha Adham,Rodica Gincul,Gilles Poncetet al. Virchows Archiv, 2011, 458 (5), pp.537-46. ⟨10.1007/s00428-011-1067-0⟩ Article dans une revue istex hal-00713749v1
Targeting the PI3K/mTOR pathway in murine endocrine cell lines: in vitro and in vivo effects on tumor cell growth. Christophe Couderc,Gilles Poncet,Karine Villaume,Martine Blanc,Nicolas Gadotet al. American Journal of Pathology, 2011, 178 (1), pp.336-44. ⟨10.1016/j.ajpath.2010.11.023⟩ Article dans une revue hal-00710288v1
18F-FLT and 18F-FDG positron emission tomography for the imaging of advanced well-differentiated gastro-entero-pancreatic endocrine tumours. Francesco Giammarile,Claire Billotey,Catherine Lombard-Bohas,Didier Le Bars,Claire Bournaudet al. Nuclear Medicine Communications, 2011, 32 (2), pp.91-7. ⟨10.1097/MNM.0b013e3283412143⟩ Article dans une revue hal-00814028v1
Transcatheter local thrombolysis in patients with extensive TIPS thrombosis J. Dumortier,T. Walter,O. Guillaud,F. Pietu,M. Vallinet al. Gastroenterol. Clin. Biol., 2010, 34 (12), pp.721--725 Article dans une revue hal-01918717v1
TIPS thrombosis related to abdominal trauma F. Pietu,T. Walter,O. Guillaud,F. Pilleul,J. Dumortier European Journal of Gastroenterology & Hepatology, 2010, 22 (7), pp.883--885 Article dans une revue hal-01918719v1
VEGF Secretion by Neuroendocrine Tumor Cells Is Inhibited by Octreotide and by Inhibitors of the PI3K/AKT/mTOR Pathway. Karine Villaume,Martine Blanc,Géraldine Gouysse,Thomas R. Walter,Christophe Coudercet al. Neuroendocrinology, 2010, epub ahead of print. ⟨10.1159/000289569⟩ Article dans une revue hal-00475083v1
Evaluation of the combination 5-fluorouracil, dacarbazine, and epirubicin in patients with advanced well-differentiated neuroendocrine tumors T. Walter,D. Bruneton,P. A. Cassier,V. Hervieu,F. Pilleulet al. Clinical Colorectal Cancer, 2010, 9 (4), pp.248--254 Article dans une revue hal-01918720v1
Angiogenesis and tumor progression in neuroendocrine digestive tumors. Gilles Poncet,Karine Villaume,Thomas Walter,Céline Pourreyron,Aurélie Theillaumaset al. Journal of Surgical Research, 2009, 154 (1), pp.68-77. ⟨10.1016/j.jss.2008.03.055⟩ Article dans une revue istex hal-00475688v1
Gemcitabine and oxaliplatin combination chemotherapy for metastatic well-differentiated neuroendocrine carcinomas: a single-center experience. Philippe A Cassier,Thomas R. Walter,Beatrice Eymard,Philippe Ardisson,Maurice Perolet al. Cancer / Cancer (Phila), 2009, epub ahead of print. ⟨10.1002/cncr.24384⟩ Article dans une revue hal-00391942v1

Communication dans un congrès (38)

Human blood biomarkers of skeletal muscle atrophy Coralie Delabrise,Julien Aniort,Cécile Polge,Agnès Claustre,Lydie Combaretet al. Journées de la Société Française de Myologie 21ème Édition, Société Française de Myologie, Nov 2024, Clermont - Ferrand, France Communication dans un congrès hal-04992128v1
Etoposide-based rechallenge and second/third line treatments in patients with metastatic neuroendocrine carcinoma: Results from the multicenter RBNEC study of the Groupe d'Etude des Tumeurs Endocrines (GTE) and the ENDOCAN-RENATEN network Thomas Walter 19th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2022, Barcelona (ES), Spain. pp.111 Communication dans un congrès hal-04490282v1
LBA46 Bevacizumab (B) plus FOLFIRI after failure of platinum-etoposide in patients (pts) with advanced neuroendocrine carcinoma (NEC): The PRODIGE 41-BEVANEC randomized phase II study Thomas Walter,A. Lievre,R. Coriat,D. Malka,F. El Hajbiet al. Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022, Sep 2022, Paris, France. pp.S1412, ⟨10.1016/j.annonc.2022.08.045⟩ Communication dans un congrès hal-04489922v1
Characterisation, prognosis, and treatment of patients with locally advanced or metastatic thymic carcinoid tumor: A retrospective study of the French GTE-ENDOCAN RENATEN and RYTHMIC networks Thomas Walter 19th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2022, Barcelona (ES), Spain. pp.73 Communication dans un congrès hal-04490299v1
Antisecretory effect of oral targeted therapies in advanced functioning neuroendocrine tumors (the ASSET-NET study) Thomas Walter 19th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2022, Barcelona (ES), Spain. pp.186 Communication dans un congrès hal-04490234v1
Surgical management of patients with sporadic Zollinger-Ellison Syndrome: An ACHBT and GTE study Thomas Walter 19th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2022, Barcelona (ES), Spain. pp.195 Communication dans un congrès hal-04490290v1
Characterising aggressive pulmonary carcinoids through integrative omics analysis Thomas Walter 19th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2022, Barcelona (ES), Spain. pp.29 Communication dans un congrès hal-04489996v1
Prognosis and the role of Rb expression in metastatic grade 3 neuroendocrine carcinoma (G3NEC), results from the multicenter retrospective RbNEC study Thomas Walter 18th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Feb 2021, Virtual conference, Germany. pp.107 Communication dans un congrès hal-04492213v1
Cost of carcinoid syndrome (CS) In France: Analysis of the national health insurance database Thomas Walter 18th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Feb 2021, Virtual conference, Germany. pp.76 Communication dans un congrès hal-04492045v1
LBA41 Nivolumab (nivo) ± ipilimumab (ipi) in pre-treated patients with advanced, refractory pulmonary or gastroenteropancreatic poorly differentiated neuroendocrine tumors (NECs) (GCO-001 NIPINEC) N. Girard,J. Mazieres,J. Otto,H. Lena,C. Lepageet al. Abstract Book of the ESMO Congress 2021, 16 – 21 September, Sep 2021, Paris, France. pp.S1318, ⟨10.1016/j.annonc.2021.08.2119⟩ Communication dans un congrès hal-04492251v1
OPERA: Observational study of perception of information and quality of life (QoL) in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) starting Lanreotide Autogel (LAN) Thomas Walter 18th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Feb 2021, Virtual conference, Germany. pp.136 Communication dans un congrès hal-04492200v1
Plasmatic and urinary 5-hydroxyindolacetic acid measurements in patients with midgut neuroendocrine tumors: A GTE study Thomas Walter 18th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Feb 2021, Virtual conference, Germany. pp.104 Communication dans un congrès hal-04492492v1
Lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumors - An international double-blind, placebo-controlled randomized phase 2. Prodige 31 REMINET. A FFCD study Thomas Walter 18th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Feb 2021, Virtual conference, Germany. pp.139 Communication dans un congrès hal-04492188v1
Efficacy of Alkylating Agent Re-challenge after Therapeutic Pause in Metastatic Pancreatic Neuroendocrine Tumors (PanNET) Thomas Walter 17th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2020, Virtual conference, Germany. pp.(H11) Communication dans un congrès hal-04493642v1
A systematic review and exploratory network meta-analysis of third-line treatments for metastatic colorectal cancer Thomas Walter ISPOR 2020 HEOR: Advancing Evidence to Action, May 2020, Orlando (FL), United States. pp.S30 Communication dans un congrès hal-04492668v1
Patient and Nurse Satisfaction with the New Lanreotide Autogel Pre-Filled Syringe in Neuroendocrine Tumors (NET): A Prospective Study (SONATE) Thomas Walter 17th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2020, Virtual conference, Germany. pp.H30 Communication dans un congrès hal-04493487v1
Impact of Small Cell (SC) versus (vs.) Non-Small Cell (nSC) Morphology on Outcomes of Patients (pts) with Extra-Pulmonary, Poorly Differentiated Neuroendocrine Carcinoma (EP-PD-NEC) Thomas Walter Abstracts of the 17th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2020, Barcelona (ES), Spain. pp.(J25) Communication dans un congrès hal-04492643v1
Differential Diagnosis (DDX) of Carcinoid Syndrome Diarrhea (CSD): A Systematic Literature Review (SLR) Thomas Walter 12th Annual Multidisciplinary Neuroendocrine Tumor Medical Symposium of the North American Neuroendocrine Tumor Society, Oct 2019, Boston (MA), United States. pp.472 Communication dans un congrès hal-04493548v1
Dacarbazine- or Temozolomide-Based Chemotherapy in Metastatic Digestive Neuroendocrine Carcinomas in Post First-line Chemotherapy: A Retrospective Multicentric Study of the French Group of Endocrine Tumours (GTE) Thomas Walter 17th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2020, Virtual conference, Germany. pp.(H08) Communication dans un congrès hal-04493659v1
OPERA: Observational Study of Perception of Information and Quality of Life in Patients with Gastroenteropancreatic NeuroEndocrine TumoRs Starting LAnreotide Autogel-Baseline Characteristics Thomas Walter 17th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2020, Virtual conference, Germany. pp.(D23) Communication dans un congrès hal-04493628v1
The PanNENomics Project: A Call for an International Collaborative Effort Built on the Success of the LungNENomics Project Thomas Walter 17th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2020, Virtual conference, Germany. pp.(C08) Communication dans un congrès hal-04493635v1
The Effect of Carcinoid Syndrome Diarrhea (CSD) Interventions on Patient Experience Outcomes: A Systematic Literature Review (SLR) Thomas Walter 16th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2019, Barcelone (ES), Spain. pp.(J15) Communication dans un congrès hal-04493864v1
Differential Diagnosis (DDx) of Carcinoid Syndrome Diarrhea (CSD): A Systematic Literature Review (SLR) Thomas Walter 16th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2019, Barcelona (ES), Spain. pp.(J08) Communication dans un congrès hal-04493888v1
Temozolomide (TEM) vs Temozolomide-Capecitabine (CAP) in Advanced Pancreatic NET (pNET): A Multicenter Retrospective Analysis of 138 Patients Using a Propensity Score Thomas Walter 6th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2019, Barcelona (ES), Spain. pp.(H08) Communication dans un congrès hal-04495620v1
Comparison of Temozolomide-Capecitabine to 5-Fluorouracile-Dacarbazine in 247 Patients with Advanced Digestive Neuroendocrine Tumors Using Propensity Score Analyses Thomas Walter 16th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2019, Barcelona (ES), France. pp.(H07) Communication dans un congrès hal-04495625v1
Carcinoid heart disease (CHD): the CRUSOE-NETs, a prospective cohort study from the French group of endocrine tumours (GTE) K. Dekeister Geoffroy,L. Francois,Thomas Walter,O. Hentic Dhome,A. Cachieret al. 44th ESMO Congress (ESMO 2019), Sep 2019, Barcelona (ES), Spain. pp.v196, ⟨10.1093/annonc/mdz245.007⟩ Communication dans un congrès hal-04493904v1
Framework synthesis of qualitative and quantitative evidence to explore the differential diagnosis of diarrhea in neuroendocrine tumor patients Thomas Walter ISPOR 2019: Rapid. Disruptive. Innovative: A New Era in HEOR, May 2019, Nouvelle Orléans (LA), United States. pp.S265 Communication dans un congrès hal-04493855v1
Endoscopic Management of 345 Small Rectal Neuroendocrine Tumours: A National Study from the French Group of Endocrine Tumours (GTE) Thomas Walter 16th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2019, Barcelona (ES), Spain. pp.(G01) Communication dans un congrès hal-04495616v1
Patient Survey Devoted to Characterizing Experience and Expectations of Patients with Neuroendocrine Tumors (NET) Thomas Walter 15th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2017, Barcelona (ES), Spain. pp.(D59) Communication dans un congrès hal-04495692v1
Everolimus after transarterial liver therapy of metastases from gastrointestinal neuroendocrine tumors: The FFCD 1104-EVACEL-GTE phase II study Thomas Walter 43rd ESMO Congress (ESMO 2018), Mar 2018, Munich (Allemagne), Germany. pp.viii469 Communication dans un congrès hal-04495683v1
Perioperative Chemotherapy in Resectable Neuroendocrine Carcinomas of the Digestive Tract Thomas Walter 15th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2018, Barcelona (ES), Spain. pp.(H20) Communication dans un congrès hal-04495718v1
REMINET : A European, Multicenter, Phase II/III Randomized Double-Blind, Placebo-Controlled Study Evaluating Lanreotide As Maintenance Therapy after First-Line Treatment in Patients with Non-Resectable Duodeno-Pancreatic Neuroendocrine Tumors C. Lepage,L. Dahan,J.-L. Legoux,K. Le Malicot,R. Guimbaudet al. The 14th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2017, Barcelone, Spain. pp.187 (J8) Communication dans un congrès hal-01664217v1
Mixed adeno-neuroendocrine carcinoma (MANEC) of the gastroenteropancreatic (GEP) tract: A multicentre retrospective study M. Frizziero,X. Wang,B. Chakrabarty,A. Childs,T.V. Luonget al. 42nd ESMO Congress (ESMO 2017), Sep 2017, Madrid (ES), Spain. pp.155, ⟨10.1093/annonc/mdx368.038⟩ Communication dans un congrès hal-04500086v1
Comparison of performances of three technologies for detection of RAS mutations in cfDNA (NGS strategy, BEAMing assay and ddPCR BioRAD assay) J. Garcia,J. Forestier,E. Dusserre,C. Rodriguez-Lafrasse,V. Cheynetet al. 42nd ESMO Congress (ESMO 2017), Sep 2017, Madrid (ES), Spain. pp.197, ⟨10.1093/annonc/mdx393.107⟩ Communication dans un congrès hal-04499713v1
Intraoperative Carcinoid Syndrome during Small-Bowel NET Surgery: Description, Prevalence and Risk Factors Thomas Walter 14th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2017, Barcelona (ES), Spain. pp.(R6) Communication dans un congrès hal-04504145v1
Treatment of Metastatic Pancreatic Neuroendocrine Tumors: Relevance of ENETS 2016 Guidelines Thomas Walter 14th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2017, Barcelone (ES), Spain. pp.(J6) Communication dans un congrès hal-04500118v1
Patient-Reported Preferences in Treatments Approved in Neuroendocrine Tumors: A National Survey from the French Group of Endocrine Tumors Thomas Walter 14th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2017, Barcelona (ES), Spain. pp.(R12) Communication dans un congrès hal-04495920v1
Implication of Neuropilin-2 in the Progression of Small Intestinal Neuroendocrine Tumors: Towards a Promising Therapeutic Target Thomas Walter 14th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2017, Barcelona (ES), Spain. pp.(A2) Communication dans un congrès hal-04504139v1

Poster de conférence (2)

FFCD Prodige 31 Reminnet Côme Lepage,L. Dahan,Jean-Louis Legoux,Karine Le Malicot,Rosine Guimbaudet al. The 14th Annual ENETS Conference, Mar 2017, Barcelone, Spain. , 2017, ⟨10.13140/RG.2.2.35427.35368⟩ Poster de conférence hal-01578731v1
MISE EN PLACE ET EVALUATION D'UNE ACTIVITE DE PHARMACIE CLINIQUE EN HOPITAL DE JOUR ONCOLOGIQUE Fiona Malagutti,Rémi Faure,Thomas Walter,Julien Forestier,Catherine Lombard-Bohaset al. Xémes Journées de la Société Française de Pharmacie Oncologique, Oct 2015, Nantes, France Poster de conférence hal-01214190v1

Autre publication scientifique (4)

Endoscopic removal of colorectal T1 cancers: Why is a 1-year follow-up recommended by ESGE when resection is R0 and curative? Mathieu Pioche,Thomas Walter 2019, pp.E816-E817. ⟨10.1055/a-0900-3878⟩ Autre publication scientifique hal-04493873v1
Response to Comment on “Current Management and Predictive Factors of Lymph Node Metastasis of Appendix Neuroendocrine Tumors: A National Study From the French Group of Endocrine Tumors (GTE)” Thomas Walter,Bérénice Rault-Petit,Jean-Yves Scoazec 2019, pp.e44-e46. ⟨10.1097/sla.0000000000003079⟩ Autre publication scientifique hal-04493856v1
No histology for diminutive duodenal neuroendocrine tumors: Is it safe? Thomas Walter 2019, pp.E308-E309. ⟨10.1055/a-0650-4478⟩ Autre publication scientifique hal-04493866v1
Everolimus in ileum neuroendocrine tumours Thomas Walter,Catherine Lombard-Bohas 2016, pp.236. ⟨10.1016/s0140-6736(16)31039-x⟩ Autre publication scientifique hal-04495964v1

Pré-publication, Document de travail (1)

Long-read sequencing identifies aberrant fragmentation patterns linked to elevated cell-free DNA levels in cancer Benjamin P Berman,Sarah A Erdman,Christina Wheeler,Justin Cayford,Jean-Valery Turatsinzeet al. 2025 Pré-publication, Document de travail hal-05339094v1